Report: Cardiolite continues to dominate radiopharmaceutical market

11/11/2008 | PharmaLive.com

Cardiolite, Lantheus Medical Imaging's myocardial perfusion imaging agent, had 15% more of the market share than Myoview, a similar product from General Electric, in September, according to a report from market research firm Arlington Medical Resources. The report also said patient use of Astellas Pharma's pharmacologic stress agent, Lexiscan, increased 58.5% from August 2008 to September 2008.

View Full Article in:

PharmaLive.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC